SourceOne® Global Partners has announced it has reached an agreement with Santal Solutions, Appleton, Wis., wherein SourceOne is awarded exclusive global distribution rights for Santal's new metabolic health and weight management product, LeptiPURE™.
LeptiPURE is a novel patented synergistic combination of GymnePURE® and the botanical extract Tinospora cordifolia. Combined in this precise and patented formulation, scientific studies demonstrate “enhanced effectiveness impacting several important health benefits.”
Protected by multiple patents, GymnePURE has been shown to support insulin production at a much lower dosage level than standard Gymnema sylvestre extracts because of SourceOne’s novel OSA™ technology. OSA technology captures the most bioactive parts of the Gymnema sylvestre leaf and produces an isolate with a specified molecular weight, which mimics a hypoglycemic agent. Tinospora cordifolia has extensive scientific evidence demonstrating its role in maintaining healthy glucose and lipid metabolism, which synergistically helps maintain a healthy adiponectin-to-leptin ratio.
LeptiPURE has been shown in initial scientific studies to increase adiponectin by 12 percent and decrease leptin levels by 25 percent. Adiponectin and leptin are key hormones that, when functioning optimally, help ensure healthy weight and metabolism. Dr. Arun K. Chatterji, CEO of Santal Solutions, comments, “The initial clinical study results are very encouraging because the science is clear: Improved ratio of leptin to adiponectin levels up to 37 percent with LeptiPURE is directly related to healthy metabolic flexibility and supporting the body’s natural ability to maintain a healthy weight.”
He continues, “We have seen significant improvement with patented GymnePURE supporting healthy lipid profiles, blood sugar, glucose, HbA1c, and CRP. This patented combination with Tinospora cordifolia (LeptiPURE) has the potential to optimize benefits seen in earlier clinical studies.”
LeptiPURE addresses the healthy maintenance of metabolic markers including blood glucose, cytokine and free radical balance, healthy cholesterol and triglyceride levels, mitochondria and endoplasmic reticulum vitality, and autophagy/apoptosis balance. The patented synergistic formula is useful in an endless number of dietary supplements including those targeted weight management, cardiovascular health, blood sugar health, brain and cognition, anti-aging and bone and joint health.
Jesse Lopez, CEO and founder of SourceOne Global Partners, explains, "This study is one example of why supplements such as LeptiPURE are very important for consumers who are concerned about achieving and maintaining healthy metabolic status. Our manufacturer partners see a growing demand from their customers for science-backed nutritional supplements that better help them maintain healthy body weight, triglyceride and cholesterol levels, as well as overall energy and fitness.”
With the addition of LeptiPURE, SourceOne builds upon its unmatched IP portfolio of natural product solutions. Lopez says, “LeptiPURE broadens and deepens our patented ingredient options, the health conditions they support, and synergistic mechanisms of action that we offer our client partners seeking to formulate products with the most science-based and patent-protected ingredients.”